# Takeda Vaccines Inc.

Canonical: https://abierto.us/vendors/takeda-vaccines-inc-xl5xeumajdq8

- UEI: XL5XEUMAJDQ8
- CAGE: 1NTS0
- Location: Deerfield, IL
- Awards in window: 1 (2 transactions), -$7,416,267 obligated, May 9, 2024 to September 26, 2024

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, -$7,416,267

## Industries

- 325413 In-Vitro Diagnostic Substance Manufacturing: -$7,416,267

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- HHSO100201600015C (definitive contract): -$7,416,267, Barda - Aspr / Daappo / Barda DCMA. This Administrative Modification Is to Extend the Period of Performance at No Cost to the Government for Option Period 5 and Option 6. the Approved Extension to the Period of Performance on Clin0006 and Clin0007 Is as Follows Clin 0006 Is 09/30/202. https://www.usaspending.gov/award/CONT_AWD_HHSO100201600015C_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/takeda-vaccines-inc-xl5xeumajdq8.